2018-02-08 11:19 ET - News Release

Mr. Boris Ziger reports

MATICA ANNOUNCES INTENT TO ACQUIRE A CONTROL POSITION IN A RESEARCH & DEVELOPMENT COMPANY

Matica Enterprises Inc. has signed a non-binding letter of intent to purchase a controlling interest in a Quebec-based health and personal care research and innovation technology company. Matica is pleased to have come to an agreement on terms and will quickly proceed to a definitive agreement.

As Matica nears the completion of its cannabis growing facility in Dorval, management recognizes the acute need for alternative cannabis delivery systems, including pain-relief topicals. With this acquisition Matica can direct research to produce new topical products such as balms, creams and salves. The target company is based just outside of Montreal and is a leader in sustainable, clean, health- and personal-care products. Using proprietary mineral- and plant-based suspension technologies which can create unique alternative clean ingredients, Matica intends to develop revolutionary topical products within the cannabis space.

After successful due diligence and signing of the definitive agreement, Matica will invest $2-million to acquire a 25-per-cent interest.

We seek Safe Harbor.